TriSalus Life Sciences In...

NASDAQ: TLSI · Real-Time Price · USD
3.96
0.08 (2.06%)
At close: Aug 15, 2025, 10:22 AM

TriSalus Life Sciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
29.43M 18.51M 12.4M 8.4M
Cost of Revenue
4.1M 2.6M 2.26M 1.19M
Gross Profit
25.33M 15.91M 10.14M 7.21M
Operating Income
-36.16M -54.15M -36.44M -24.03M
Interest Income
404K 431K 180K n/a
Pretax Income
-30.04M -59.03M -47.18M -28.84M
Net Income
-33.23M -59.04M -47.19M -28.84M
Selling & General & Admin
43.8M 40.55M 25.22M 17.02M
Research & Development
17.69M 29.51M 21.36M 14.22M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
61.49M 70.06M 46.58M 31.24M
Interest Expense
3.09M 16K 1K 1.76M
Selling & Marketing Expenses
25.84M 17.03M 12.74M 8.26M
Cost & Expenses
65.6M 72.66M 48.84M 32.43M
Income Tax Expense
6K 9K 9K 3K
Shares Outstanding (Basic)
26.5M 26.47M 29.61M 31.25M
Shares Outstanding (Diluted)
26.5M 26.47M 29.61M 31.25M
EPS (Basic)
-1.25 -2.23 -1.59 -0.92
EPS (Diluted)
-1.25 -2.23 -1.59 -0.92
EBITDA
-36.16M -58.3M -46.76M -23.57M
EBIT
-33.13M -59.01M -47.18M -24.03M
Depreciation & Amortization
-3.04M 702K 414K 464K